Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    10.50
    0.37 (3.63%)
    At close: Jun 16, 2025, 1:01 PM

    Innovent Biologics Statistics

    Share Statistics

    Innovent Biologics has 1.65B shares outstanding. The number of shares has increased by 0.62% in one year.

    Shares Outstanding

    n/a
    		 1.65B

    Shares Change (YoY)

    n/a
    		 0.62%

    Shares Change (QoQ)

    n/a
    		 0.01%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 1.53B

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 3.4M, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.4M

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 999.99

    Valuation Ratios

    The PE ratio is -547.41 and the forward PE ratio is 12.06. Innovent Biologics's PEG ratio is 6.

    PE Ratio

    n/a
    		 -547.41

    Forward PE

    n/a
    		 12.06

    PS Ratio

    n/a
    		 5.5

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 3.95

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 6
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Innovent Biologics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.22.

    Current Ratio

    n/a
    		 2.35

    Quick Ratio

    n/a
    		 2.16

    Debt / Equity

    n/a
    		 0.22

    Debt / EBITDA

    n/a
    		 -5.89

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,664,938.68

    Profits Per Employee

    n/a
    		 $-16,722.21

    Employee Count

    n/a
    		 5,659

    Asset Turnover

    n/a
    		 0.44

    Inventory Turnover

    n/a
    		 1.84

    Taxes

    Income Tax

    n/a
    		 16.01M

    Effective Tax Rate

    n/a
    		 -20.36%

    Stock Price Statistics

    The stock price has increased by 112.98% in the last 52 weeks. The beta is 0.23, so Innovent Biologics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.23

    52-Week Price Change

    n/a
    		 112.98%

    50-Day Moving Average

    n/a
    		 7.04

    200-Day Moving Average

    n/a
    		 5.54

    Relative Strength Index (RSI)

    n/a
    		 86.18

    Average Volume (20 Days)

    n/a
    		 3,310

    Income Statement

    In the last 12 months, Innovent Biologics had revenue of 9.42B and earned -94.63M in profits. Earnings per share was -0.06.

    Revenue

    n/a
    		 9.42B

    Gross Profit

    n/a
    		 7.91B

    Operating Income

    n/a
    		 -755.87M

    Net Income

    n/a
    		 -94.63M

    EBITDA

    n/a
    		 -480.28M

    EBIT

    n/a
    		 -755.87M

    Earnings Per Share (EPS)

    n/a
    		 -0.06
    Full Income Statement

    Balance Sheet

    The company has 7.51B in cash and 2.83B in debt, giving a net cash position of 4.68B.

    Cash & Cash Equivalents

    n/a
    		 7.51B

    Total Debt

    n/a
    		 2.83B

    Net Cash

    n/a
    		 4.68B

    Retained Earnings

    n/a
    		 n/a

    Total Assets

    n/a
    		 21.6B

    Working Capital

    n/a
    		 5.9B
    Full Balance Sheet

    Cash Flow

    Operating Cash Flow

    n/a
    		 n/a

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 n/a

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 83.97%, with operating and profit margins of -8.02% and -1%.

    Gross Margin

    n/a
    		 83.97%

    Operating Margin

    n/a
    		 -8.02%

    Pretax Margin

    n/a
    		 -0.83%

    Profit Margin

    n/a
    		 -1%

    EBITDA Margin

    n/a
    		 -5.1%

    EBIT Margin

    n/a
    		 -8.02%

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    IVBXF does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for IVBXF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.56

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist